Tradewinds LLC. Makes New $969,000 Investment in Alpha Teknova, Inc. $TKNO

Tradewinds LLC. bought a new stake in shares of Alpha Teknova, Inc. (NASDAQ:TKNO) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 156,529 shares of the company’s stock, valued at approximately $969,000. Tradewinds LLC. owned approximately 0.29% of Alpha Teknova at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Conestoga Capital Advisors LLC increased its holdings in shares of Alpha Teknova by 60.7% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 308,939 shares of the company’s stock valued at $1,912,000 after acquiring an additional 116,665 shares during the last quarter. Whalen Wealth Management Inc. bought a new stake in Alpha Teknova during the third quarter worth approximately $77,000. Massar Capital Management LP grew its holdings in Alpha Teknova by 185.7% during the second quarter. Massar Capital Management LP now owns 200,000 shares of the company’s stock valued at $982,000 after purchasing an additional 130,000 shares during the last quarter. Balyasny Asset Management L.P. raised its position in shares of Alpha Teknova by 19.5% in the second quarter. Balyasny Asset Management L.P. now owns 1,000,484 shares of the company’s stock valued at $4,912,000 after purchasing an additional 163,526 shares during the period. Finally, Bank of America Corp DE lifted its stake in shares of Alpha Teknova by 3.3% in the second quarter. Bank of America Corp DE now owns 229,429 shares of the company’s stock worth $1,126,000 after buying an additional 7,256 shares during the last quarter. Institutional investors own 13.81% of the company’s stock.

Alpha Teknova Price Performance

Shares of Alpha Teknova stock opened at $3.32 on Monday. The company has a debt-to-equity ratio of 0.18, a current ratio of 5.27 and a quick ratio of 4.27. The company has a market cap of $177.72 million, a PE ratio of -9.49 and a beta of 0.42. The firm has a fifty day moving average price of $4.36 and a two-hundred day moving average price of $4.70. Alpha Teknova, Inc. has a fifty-two week low of $3.27 and a fifty-two week high of $10.37.

Alpha Teknova (NASDAQ:TKNO) last announced its quarterly earnings data on Thursday, November 6th. The company reported ($0.08) EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.01. Alpha Teknova had a negative net margin of 45.78% and a negative return on equity of 23.53%. The business had revenue of $10.45 million during the quarter, compared to analyst estimates of $10.23 million. Analysts expect that Alpha Teknova, Inc. will post -0.58 EPS for the current year.

Analyst Ratings Changes

TKNO has been the topic of a number of research analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Alpha Teknova in a research note on Wednesday, October 8th. Zacks Research raised Alpha Teknova to a “hold” rating in a research report on Wednesday, December 10th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $10.00.

About Alpha Teknova

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.